The Food and Drug Administration approved Veklury — also known as the drug remdesivir — as the first COVID-19 treatment for children younger than 12 on Monday, April 25.
Now, pediatric patients 28 days and older, and weighing at least 7 pounds, can get the treatment after being hospitalized with COVID-19, according to an FDA news release.
The antiviral medicine, created by Gilead Sciences, can also be given to pediatric patients who “have mild-to-moderate COVID-19 and are at high risk for progression to severe COVID-19, including hospitalization or death,” the agency said.
